CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell CarcinomaYohei Sekino, Jun Teishima|Anticancer Research|2021Cited by 13
P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell CarcinomaYohei Sekino, Jun Teishima|Anticancer Research|2021Cited by 10
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate CancerYohei Sekino, Jun Teishima|Biomedicines|2021Cited by 9